nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—TOP2A—malignant glioma	0.792	1	CbGaD
Amsacrine—Myelosuppression—Carmustine—malignant glioma	0.00352	0.0375	CcSEcCtD
Amsacrine—Myelosuppression—Temozolomide—malignant glioma	0.0034	0.0363	CcSEcCtD
Amsacrine—NCOA3—brainstem—malignant glioma	0.00307	0.106	CbGeAlD
Amsacrine—NCOA3—retina—malignant glioma	0.00296	0.102	CbGeAlD
Amsacrine—Febrile neutropenia—Carmustine—malignant glioma	0.00274	0.0292	CcSEcCtD
Amsacrine—NCOA3—telencephalon—malignant glioma	0.00272	0.0941	CbGeAlD
Amsacrine—Febrile neutropenia—Temozolomide—malignant glioma	0.00265	0.0283	CcSEcCtD
Amsacrine—NCOA3—medulla oblongata—malignant glioma	0.00214	0.0739	CbGeAlD
Amsacrine—Hepatotoxicity—Carmustine—malignant glioma	0.00214	0.0228	CcSEcCtD
Amsacrine—Necrosis—Carmustine—malignant glioma	0.0021	0.0224	CcSEcCtD
Amsacrine—Hepatotoxicity—Temozolomide—malignant glioma	0.00206	0.022	CcSEcCtD
Amsacrine—NCOA3—midbrain—malignant glioma	0.00195	0.0676	CbGeAlD
Amsacrine—NCOA3—spinal cord—malignant glioma	0.00191	0.0659	CbGeAlD
Amsacrine—Extravasation—Carmustine—malignant glioma	0.00189	0.0202	CcSEcCtD
Amsacrine—Injection site reaction—Carmustine—malignant glioma	0.00164	0.0175	CcSEcCtD
Amsacrine—Musculoskeletal pain—Temozolomide—malignant glioma	0.00161	0.0172	CcSEcCtD
Amsacrine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00159	0.017	CcSEcCtD
Amsacrine—NCOA3—central nervous system—malignant glioma	0.00155	0.0535	CbGeAlD
Amsacrine—NCOA3—cerebellum—malignant glioma	0.00151	0.0523	CbGeAlD
Amsacrine—Aplastic anaemia—Temozolomide—malignant glioma	0.0015	0.016	CcSEcCtD
Amsacrine—Sepsis—Carmustine—malignant glioma	0.00143	0.0153	CcSEcCtD
Amsacrine—Phlebitis—Carmustine—malignant glioma	0.00139	0.0148	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00133	0.0142	CcSEcCtD
Amsacrine—Vascular purpura—Temozolomide—malignant glioma	0.00129	0.0138	CcSEcCtD
Amsacrine—Hepatic failure—Temozolomide—malignant glioma	0.00129	0.0137	CcSEcCtD
Amsacrine—NCOA3—brain—malignant glioma	0.00123	0.0425	CbGeAlD
Amsacrine—Purpura—Temozolomide—malignant glioma	0.0012	0.0128	CcSEcCtD
Amsacrine—Affect lability—Temozolomide—malignant glioma	0.00114	0.0121	CcSEcCtD
Amsacrine—Mood swings—Temozolomide—malignant glioma	0.0011	0.0117	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00104	0.0111	CcSEcCtD
Amsacrine—Dysphagia—Carmustine—malignant glioma	0.00104	0.011	CcSEcCtD
Amsacrine—Dysphagia—Temozolomide—malignant glioma	0.001	0.0107	CcSEcCtD
Amsacrine—Pancytopenia—Carmustine—malignant glioma	0.000983	0.0105	CcSEcCtD
Amsacrine—Pancytopenia—Temozolomide—malignant glioma	0.00095	0.0101	CcSEcCtD
Amsacrine—Weight increased—Temozolomide—malignant glioma	0.00091	0.00971	CcSEcCtD
Amsacrine—Renal failure—Carmustine—malignant glioma	0.000907	0.00967	CcSEcCtD
Amsacrine—Weight decreased—Temozolomide—malignant glioma	0.000905	0.00965	CcSEcCtD
Amsacrine—Stomatitis—Carmustine—malignant glioma	0.0009	0.00959	CcSEcCtD
Amsacrine—KCNH2—telencephalon—malignant glioma	0.000895	0.0309	CbGeAlD
Amsacrine—Infestation NOS—Temozolomide—malignant glioma	0.000892	0.00951	CcSEcCtD
Amsacrine—Infestation—Temozolomide—malignant glioma	0.000892	0.00951	CcSEcCtD
Amsacrine—Stomatitis—Temozolomide—malignant glioma	0.000869	0.00927	CcSEcCtD
Amsacrine—Hepatobiliary disease—Temozolomide—malignant glioma	0.000844	0.00899	CcSEcCtD
Amsacrine—Haemoglobin—Carmustine—malignant glioma	0.000833	0.00888	CcSEcCtD
Amsacrine—Haemorrhage—Carmustine—malignant glioma	0.000829	0.00883	CcSEcCtD
Amsacrine—Hypoaesthesia—Carmustine—malignant glioma	0.000824	0.00879	CcSEcCtD
Amsacrine—Connective tissue disorder—Carmustine—malignant glioma	0.000814	0.00868	CcSEcCtD
Amsacrine—ABCB1—blood vessel—malignant glioma	0.000809	0.028	CbGeAlD
Amsacrine—Haemoglobin—Temozolomide—malignant glioma	0.000805	0.00858	CcSEcCtD
Amsacrine—Haemorrhage—Temozolomide—malignant glioma	0.000801	0.00854	CcSEcCtD
Amsacrine—Hepatitis—Temozolomide—malignant glioma	0.000801	0.00854	CcSEcCtD
Amsacrine—Hypoaesthesia—Temozolomide—malignant glioma	0.000797	0.00849	CcSEcCtD
Amsacrine—Urinary tract disorder—Temozolomide—malignant glioma	0.000791	0.00843	CcSEcCtD
Amsacrine—Connective tissue disorder—Temozolomide—malignant glioma	0.000787	0.00839	CcSEcCtD
Amsacrine—Urethral disorder—Temozolomide—malignant glioma	0.000785	0.00837	CcSEcCtD
Amsacrine—Cardiac disorder—Temozolomide—malignant glioma	0.000743	0.00792	CcSEcCtD
Amsacrine—Arrhythmia—Carmustine—malignant glioma	0.00074	0.00789	CcSEcCtD
Amsacrine—Alopecia—Carmustine—malignant glioma	0.000732	0.00781	CcSEcCtD
Amsacrine—Angiopathy—Temozolomide—malignant glioma	0.000726	0.00775	CcSEcCtD
Amsacrine—Mental disorder—Carmustine—malignant glioma	0.000726	0.00774	CcSEcCtD
Amsacrine—Mediastinal disorder—Temozolomide—malignant glioma	0.000722	0.00769	CcSEcCtD
Amsacrine—Malnutrition—Carmustine—malignant glioma	0.000721	0.00769	CcSEcCtD
Amsacrine—Alopecia—Temozolomide—malignant glioma	0.000708	0.00754	CcSEcCtD
Amsacrine—KCNH2—medulla oblongata—malignant glioma	0.000703	0.0243	CbGeAlD
Amsacrine—Mental disorder—Temozolomide—malignant glioma	0.000701	0.00748	CcSEcCtD
Amsacrine—Malnutrition—Temozolomide—malignant glioma	0.000697	0.00743	CcSEcCtD
Amsacrine—Vision blurred—Carmustine—malignant glioma	0.00068	0.00725	CcSEcCtD
Amsacrine—Anaemia—Carmustine—malignant glioma	0.000667	0.00711	CcSEcCtD
Amsacrine—Vision blurred—Temozolomide—malignant glioma	0.000657	0.007	CcSEcCtD
Amsacrine—Leukopenia—Carmustine—malignant glioma	0.000646	0.00688	CcSEcCtD
Amsacrine—Anaemia—Temozolomide—malignant glioma	0.000644	0.00687	CcSEcCtD
Amsacrine—KCNH2—midbrain—malignant glioma	0.000643	0.0222	CbGeAlD
Amsacrine—KCNH2—spinal cord—malignant glioma	0.000627	0.0217	CbGeAlD
Amsacrine—Convulsion—Carmustine—malignant glioma	0.000625	0.00666	CcSEcCtD
Amsacrine—Leukopenia—Temozolomide—malignant glioma	0.000624	0.00665	CcSEcCtD
Amsacrine—CYP2D6—brainstem—malignant glioma	0.000615	0.0213	CbGeAlD
Amsacrine—Convulsion—Temozolomide—malignant glioma	0.000604	0.00644	CcSEcCtD
Amsacrine—Confusional state—Carmustine—malignant glioma	0.000594	0.00633	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000589	0.00628	CcSEcCtD
Amsacrine—Infection—Carmustine—malignant glioma	0.000585	0.00624	CcSEcCtD
Amsacrine—Thrombocytopenia—Carmustine—malignant glioma	0.000576	0.00615	CcSEcCtD
Amsacrine—Tachycardia—Carmustine—malignant glioma	0.000575	0.00613	CcSEcCtD
Amsacrine—Confusional state—Temozolomide—malignant glioma	0.000574	0.00612	CcSEcCtD
Amsacrine—Infection—Temozolomide—malignant glioma	0.000565	0.00603	CcSEcCtD
Amsacrine—Anorexia—Carmustine—malignant glioma	0.000561	0.00598	CcSEcCtD
Amsacrine—Thrombocytopenia—Temozolomide—malignant glioma	0.000557	0.00594	CcSEcCtD
Amsacrine—Skin disorder—Temozolomide—malignant glioma	0.000553	0.00589	CcSEcCtD
Amsacrine—Hypotension—Carmustine—malignant glioma	0.00055	0.00586	CcSEcCtD
Amsacrine—CYP2D6—telencephalon—malignant glioma	0.000546	0.0189	CbGeAlD
Amsacrine—Anorexia—Temozolomide—malignant glioma	0.000542	0.00578	CcSEcCtD
Amsacrine—Paraesthesia—Carmustine—malignant glioma	0.000529	0.00564	CcSEcCtD
Amsacrine—Dyspnoea—Carmustine—malignant glioma	0.000525	0.0056	CcSEcCtD
Amsacrine—Decreased appetite—Carmustine—malignant glioma	0.000512	0.00546	CcSEcCtD
Amsacrine—Paraesthesia—Temozolomide—malignant glioma	0.000511	0.00545	CcSEcCtD
Amsacrine—KCNH2—central nervous system—malignant glioma	0.000509	0.0176	CbGeAlD
Amsacrine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000508	0.00542	CcSEcCtD
Amsacrine—Dyspnoea—Temozolomide—malignant glioma	0.000507	0.00541	CcSEcCtD
Amsacrine—Pain—Carmustine—malignant glioma	0.000503	0.00537	CcSEcCtD
Amsacrine—KCNH2—cerebellum—malignant glioma	0.000497	0.0172	CbGeAlD
Amsacrine—Decreased appetite—Temozolomide—malignant glioma	0.000495	0.00527	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000491	0.00524	CcSEcCtD
Amsacrine—Fatigue—Temozolomide—malignant glioma	0.00049	0.00523	CcSEcCtD
Amsacrine—Pain—Temozolomide—malignant glioma	0.000486	0.00519	CcSEcCtD
Amsacrine—Feeling abnormal—Carmustine—malignant glioma	0.000485	0.00517	CcSEcCtD
Amsacrine—ABCB1—embryo—malignant glioma	0.000483	0.0167	CbGeAlD
Amsacrine—Gastrointestinal pain—Carmustine—malignant glioma	0.000481	0.00513	CcSEcCtD
Amsacrine—Feeling abnormal—Temozolomide—malignant glioma	0.000469	0.005	CcSEcCtD
Amsacrine—Abdominal pain—Carmustine—malignant glioma	0.000465	0.00496	CcSEcCtD
Amsacrine—Body temperature increased—Carmustine—malignant glioma	0.000465	0.00496	CcSEcCtD
Amsacrine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000465	0.00496	CcSEcCtD
Amsacrine—Urticaria—Temozolomide—malignant glioma	0.000452	0.00482	CcSEcCtD
Amsacrine—Abdominal pain—Temozolomide—malignant glioma	0.00045	0.00479	CcSEcCtD
Amsacrine—Body temperature increased—Temozolomide—malignant glioma	0.00045	0.00479	CcSEcCtD
Amsacrine—Hypersensitivity—Carmustine—malignant glioma	0.000434	0.00462	CcSEcCtD
Amsacrine—ABCB1—retina—malignant glioma	0.000427	0.0148	CbGeAlD
Amsacrine—Asthenia—Carmustine—malignant glioma	0.000422	0.0045	CcSEcCtD
Amsacrine—Hypersensitivity—Temozolomide—malignant glioma	0.000419	0.00447	CcSEcCtD
Amsacrine—Asthenia—Temozolomide—malignant glioma	0.000408	0.00435	CcSEcCtD
Amsacrine—KCNH2—brain—malignant glioma	0.000404	0.014	CbGeAlD
Amsacrine—Diarrhoea—Carmustine—malignant glioma	0.000403	0.00429	CcSEcCtD
Amsacrine—ABCB1—telencephalon—malignant glioma	0.000393	0.0136	CbGeAlD
Amsacrine—Dizziness—Carmustine—malignant glioma	0.000389	0.00415	CcSEcCtD
Amsacrine—Diarrhoea—Temozolomide—malignant glioma	0.000389	0.00415	CcSEcCtD
Amsacrine—Dizziness—Temozolomide—malignant glioma	0.000376	0.00401	CcSEcCtD
Amsacrine—Vomiting—Carmustine—malignant glioma	0.000374	0.00399	CcSEcCtD
Amsacrine—Rash—Carmustine—malignant glioma	0.000371	0.00396	CcSEcCtD
Amsacrine—Dermatitis—Carmustine—malignant glioma	0.000371	0.00395	CcSEcCtD
Amsacrine—Headache—Carmustine—malignant glioma	0.000369	0.00393	CcSEcCtD
Amsacrine—Vomiting—Temozolomide—malignant glioma	0.000362	0.00386	CcSEcCtD
Amsacrine—Rash—Temozolomide—malignant glioma	0.000359	0.00382	CcSEcCtD
Amsacrine—Dermatitis—Temozolomide—malignant glioma	0.000358	0.00382	CcSEcCtD
Amsacrine—Headache—Temozolomide—malignant glioma	0.000356	0.0038	CcSEcCtD
Amsacrine—Nausea—Carmustine—malignant glioma	0.00035	0.00373	CcSEcCtD
Amsacrine—Nausea—Temozolomide—malignant glioma	0.000338	0.0036	CcSEcCtD
Amsacrine—CYP2D6—central nervous system—malignant glioma	0.00031	0.0107	CbGeAlD
Amsacrine—ABCB1—medulla oblongata—malignant glioma	0.000308	0.0107	CbGeAlD
Amsacrine—CYP2D6—cerebellum—malignant glioma	0.000303	0.0105	CbGeAlD
Amsacrine—ABCB1—midbrain—malignant glioma	0.000282	0.00975	CbGeAlD
Amsacrine—ABCB1—spinal cord—malignant glioma	0.000275	0.00951	CbGeAlD
Amsacrine—CYP2D6—brain—malignant glioma	0.000246	0.00851	CbGeAlD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000243	0.00285	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—PTEN—malignant glioma	0.000238	0.0028	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—BCAN—malignant glioma	0.000233	0.00275	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00023	0.0027	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000228	0.00268	CbGpPWpGaD
Amsacrine—ABCB1—central nervous system—malignant glioma	0.000223	0.00771	CbGeAlD
Amsacrine—NCOA3—Androgen receptor signaling pathway—AKT1—malignant glioma	0.000222	0.00261	CbGpPWpGaD
Amsacrine—ABCB1—cerebellum—malignant glioma	0.000218	0.00754	CbGeAlD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—STAT3—malignant glioma	0.000213	0.00251	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000213	0.00251	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000213	0.0025	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—TFRC—malignant glioma	0.000211	0.00248	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.00021	0.00246	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000205	0.00241	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—NTRK1—malignant glioma	0.000205	0.00241	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.000204	0.0024	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.000204	0.0024	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—PTK2—malignant glioma	0.000203	0.00239	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—HLA-C—malignant glioma	0.0002	0.00235	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—HES1—malignant glioma	0.0002	0.00235	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NCOR1—malignant glioma	0.000199	0.00234	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000198	0.00233	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000196	0.00231	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—EGFR—malignant glioma	0.000194	0.00228	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000194	0.00228	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—IDH2—malignant glioma	0.000188	0.00221	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—KRAS—malignant glioma	0.000183	0.00215	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—BCHE—malignant glioma	0.000182	0.00214	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—NCOR1—malignant glioma	0.000179	0.0021	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000178	0.0021	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000178	0.0021	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000177	0.00209	CbGpPWpGaD
Amsacrine—ABCB1—brain—malignant glioma	0.000177	0.00612	CbGeAlD
Amsacrine—NCOA3—Metabolism—CYP2B6—malignant glioma	0.000177	0.00208	CbGpPWpGaD
Amsacrine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000175	0.00206	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.000174	0.00205	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000174	0.00205	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000172	0.00202	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—PLK1—malignant glioma	0.000172	0.00202	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—SLC6A3—malignant glioma	0.000171	0.00201	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	0.00017	0.002	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—FGFR1—malignant glioma	0.00017	0.002	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL12B—malignant glioma	0.00017	0.002	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—IDH1—malignant glioma	0.000162	0.0019	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—KDR—malignant glioma	0.00016	0.00188	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000159	0.00188	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MET—malignant glioma	0.000157	0.00184	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SPHK1—malignant glioma	0.000157	0.00184	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000154	0.00181	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—PLK1—malignant glioma	0.000154	0.00181	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP2C18—malignant glioma	0.000153	0.0018	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—HIST1H3B—malignant glioma	0.000152	0.00179	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NOTCH1—malignant glioma	0.000151	0.00177	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	0.000148	0.00174	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.000145	0.00171	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—PTPN11—malignant glioma	0.000145	0.0017	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000145	0.0017	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000143	0.00168	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.000143	0.00168	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—PPARG—malignant glioma	0.000142	0.00167	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.000141	0.00166	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.000139	0.00163	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000138	0.00163	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—AKT1—malignant glioma	0.000137	0.00162	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000137	0.00161	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—AKT2—malignant glioma	0.000135	0.00159	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000132	0.00155	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.000131	0.00155	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MMP2—malignant glioma	0.000131	0.00154	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PPARG—malignant glioma	0.000128	0.00151	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000127	0.0015	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.000127	0.00149	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000127	0.00149	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—FGF2—malignant glioma	0.000124	0.00146	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTT1—malignant glioma	0.000124	0.00146	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.000122	0.00144	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.000121	0.00142	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.00012	0.00142	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	0.000119	0.0014	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—HLA-B—malignant glioma	0.000118	0.00139	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—H3F3A—malignant glioma	0.000117	0.00138	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000117	0.00138	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000117	0.00137	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000116	0.00137	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS1—malignant glioma	0.000116	0.00137	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000116	0.00136	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—RAF1—malignant glioma	0.000116	0.00136	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000116	0.00136	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—ERBB2—malignant glioma	0.000115	0.00135	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—YWHAE—malignant glioma	0.000113	0.00133	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000111	0.00131	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000111	0.0013	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000111	0.0013	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000111	0.0013	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—HLA-A—malignant glioma	0.00011	0.00129	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000109	0.00128	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000109	0.00128	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—BCHE—malignant glioma	0.000108	0.00127	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000107	0.00126	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SLC5A5—malignant glioma	0.000107	0.00126	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000105	0.00124	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000101	0.00119	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—MYC—malignant glioma	0.0001	0.00118	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.0001	0.00118	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTT1—malignant glioma	9.87e-05	0.00116	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	9.87e-05	0.00116	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MMP9—malignant glioma	9.83e-05	0.00116	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	9.75e-05	0.00115	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2B—malignant glioma	9.51e-05	0.00112	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—malignant glioma	9.4e-05	0.0011	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—BRAF—malignant glioma	9.28e-05	0.00109	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—PTGS1—malignant glioma	9.25e-05	0.00109	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CD80—malignant glioma	9.25e-05	0.00109	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	9.16e-05	0.00108	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	9.03e-05	0.00106	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	9e-05	0.00106	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—VEGFA—malignant glioma	8.82e-05	0.00104	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PTEN—malignant glioma	8.79e-05	0.00103	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—STAT3—malignant glioma	8.74e-05	0.00103	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.73e-05	0.00103	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTP1—malignant glioma	8.6e-05	0.00101	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—BRCA2—malignant glioma	8.58e-05	0.00101	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN2B—malignant glioma	8.5e-05	0.001	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CAT—malignant glioma	8.37e-05	0.000984	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	8.27e-05	0.000973	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	8.23e-05	0.000968	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—BIRC5—malignant glioma	8.21e-05	0.000965	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TNF—malignant glioma	8.05e-05	0.000947	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—EGFR—malignant glioma	7.94e-05	0.000934	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—NCOR1—malignant glioma	7.9e-05	0.000929	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—MDM2—malignant glioma	7.77e-05	0.000914	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—RAF1—malignant glioma	7.74e-05	0.000911	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	7.61e-05	0.000895	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TNF—malignant glioma	7.56e-05	0.000889	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—KRAS—malignant glioma	7.5e-05	0.000882	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	7.45e-05	0.000876	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	7.44e-05	0.000875	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—RTEL1—malignant glioma	7.34e-05	0.000863	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—BIRC5—malignant glioma	7.34e-05	0.000863	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IFNG—malignant glioma	7.31e-05	0.00086	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	7.2e-05	0.000846	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TERT—malignant glioma	7.11e-05	0.000836	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	7.09e-05	0.000834	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	7.03e-05	0.000827	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	7.02e-05	0.000825	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	7e-05	0.000823	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—RTEL1—malignant glioma	6.92e-05	0.000814	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTP1—malignant glioma	6.84e-05	0.000805	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CXCL8—malignant glioma	6.8e-05	0.000799	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	6.75e-05	0.000794	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	6.53e-05	0.000767	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL1B—malignant glioma	6.52e-05	0.000767	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CASP3—malignant glioma	6.51e-05	0.000765	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL2—malignant glioma	6.5e-05	0.000764	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	6.47e-05	0.000761	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	6.46e-05	0.00076	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CAV1—malignant glioma	6.44e-05	0.000758	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	6.38e-05	0.00075	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	6.25e-05	0.000735	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.16e-05	0.000724	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—malignant glioma	6e-05	0.000706	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	5.88e-05	0.000691	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CG—malignant glioma	5.87e-05	0.00069	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PPARG—malignant glioma	5.66e-05	0.000666	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—AKT1—malignant glioma	5.63e-05	0.000662	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—malignant glioma	5.52e-05	0.000649	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2A—malignant glioma	5.44e-05	0.00064	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	5.28e-05	0.000621	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	5.25e-05	0.000617	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CD—malignant glioma	5.16e-05	0.000607	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN2A—malignant glioma	4.86e-05	0.000572	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TNF—malignant glioma	4.73e-05	0.000556	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MDM2—malignant glioma	4.72e-05	0.000555	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	4.7e-05	0.000553	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	4.56e-05	0.000536	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	4.5e-05	0.00053	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CB—malignant glioma	4.5e-05	0.000529	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS2—malignant glioma	4.46e-05	0.000524	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—COX8A—malignant glioma	4.22e-05	0.000496	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	4.07e-05	0.000478	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—COX8A—malignant glioma	3.97e-05	0.000467	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTEN—malignant glioma	3.89e-05	0.000457	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	3.83e-05	0.000451	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MYC—malignant glioma	3.69e-05	0.000433	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	3.64e-05	0.000428	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	3.59e-05	0.000422	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ASMT—malignant glioma	3.59e-05	0.000422	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	3.58e-05	0.000421	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	3.58e-05	0.00042	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	3.54e-05	0.000416	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	3.46e-05	0.000407	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ASMT—malignant glioma	3.38e-05	0.000397	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—BCAN—malignant glioma	3.37e-05	0.000396	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MYC—malignant glioma	3.3e-05	0.000388	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.29e-05	0.000387	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	3.21e-05	0.000378	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—BCAN—malignant glioma	3.18e-05	0.000374	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.13e-05	0.000368	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.02e-05	0.000355	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CA—malignant glioma	2.74e-05	0.000322	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.72e-05	0.00032	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—IDH2—malignant glioma	2.72e-05	0.00032	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—malignant glioma	2.71e-05	0.000318	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—IDH2—malignant glioma	2.56e-05	0.000301	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2B6—malignant glioma	2.55e-05	0.0003	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.51e-05	0.000295	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.45e-05	0.000288	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP2B6—malignant glioma	2.41e-05	0.000283	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—IDH1—malignant glioma	2.34e-05	0.000275	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.34e-05	0.000275	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.32e-05	0.000272	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SPHK1—malignant glioma	2.26e-05	0.000266	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKT1—malignant glioma	2.24e-05	0.000263	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2C18—malignant glioma	2.21e-05	0.00026	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—IDH1—malignant glioma	2.2e-05	0.000259	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SPHK1—malignant glioma	2.13e-05	0.000251	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.13e-05	0.00025	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP2C18—malignant glioma	2.09e-05	0.000245	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.06e-05	0.000242	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTT1—malignant glioma	1.79e-05	0.000211	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.74e-05	0.000204	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTT1—malignant glioma	1.69e-05	0.000199	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS1—malignant glioma	1.68e-05	0.000197	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS1—malignant glioma	1.58e-05	0.000186	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—BCHE—malignant glioma	1.56e-05	0.000184	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC5A5—malignant glioma	1.54e-05	0.000181	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—BCHE—malignant glioma	1.47e-05	0.000173	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.45e-05	0.000171	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.42e-05	0.000167	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTP1—malignant glioma	1.24e-05	0.000146	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CAT—malignant glioma	1.21e-05	0.000142	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTP1—malignant glioma	1.17e-05	0.000138	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOR1—malignant glioma	1.14e-05	0.000134	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CAT—malignant glioma	1.14e-05	0.000134	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOR1—malignant glioma	1.08e-05	0.000126	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CAV1—malignant glioma	9.3e-06	0.000109	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CAV1—malignant glioma	8.76e-06	0.000103	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CG—malignant glioma	8.47e-06	9.96e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARG—malignant glioma	8.18e-06	9.62e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CG—malignant glioma	7.98e-06	9.39e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARG—malignant glioma	7.71e-06	9.06e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CD—malignant glioma	7.45e-06	8.76e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CD—malignant glioma	7.02e-06	8.25e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CB—malignant glioma	6.49e-06	7.63e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS2—malignant glioma	6.43e-06	7.56e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CB—malignant glioma	6.12e-06	7.19e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS2—malignant glioma	6.06e-06	7.13e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTEN—malignant glioma	5.61e-06	6.6e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTEN—malignant glioma	5.29e-06	6.22e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CA—malignant glioma	3.96e-06	4.65e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.73e-06	4.39e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKT1—malignant glioma	3.23e-06	3.8e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKT1—malignant glioma	3.05e-06	3.58e-05	CbGpPWpGaD
